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postoperative visit (r = 0.25, p = 0.02) but not 








association between MME prescribed and 
fracture characteristics or patient variables.
Conclusion: Postoperative opioid use 









but did not correlate with injury mechanism, 
fracture characteristics, or patient variables. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.063
References 
1 Sairam Atluri, M.G.S., MD; Laxmaiah Manchikanti, 
MD, Assessment of the Trends of Medical Use and 
Misuse of Opioid Analgesics from 2004 to 2011. Pain 
Physician, 2014. 17: p. E119-E128.
2 Laxmaiah Manchikanti, M.A.S., BS, BA, Therapeutic 
Opioids: A Ten-Year Perspective on the Complexities 
and Complications the Escalating Use, Abuse, and 
Nonmedical Use of Opioids. Pain Physician, 2008. 
11: p. S63-S88.
3 Boylan, M.R., et al., Patterns of Narcotic Prescribing 
by Orthopedic Surgeons for Medicare Patients. Am J 
Med Qual, 2018: p. 1062860618771190.
4 Attum, B., et al., Opioid Prescribing Practices 
by Orthopaedic Trauma Surgeons After Isolated 
Femur Fractures. J Orthop Trauma, 2018. 32(3): p. 
e106-e111.
5 Yu, N.N., et al., Persistence of Opioid Prescribing after 
a Forearm or Lower Leg Fracture. J Gen Intern Med, 
2018. 33(3): p. 251-252.
6 Teng, Z., et al., Opioids contribute to fracture risk: a 
meta-analysis of 8 cohort studies. PLoS One, 2015. 
10(6): p. e0128232.
7 Ping, F., et al., Opioids increase hip fracture risk: a 
meta-analysis. J Bone Miner Metab, 2017. 35(3): p. 
289-297.
8 Buchheit, T., et al., Opioid exposure is associated with 
nonunion risk in a traumatically injured population: 
An inception cohort study. , 2018.
9 Seth, P., et al., Quantifying the Epidemic of 
Prescription Opioid Overdose Deaths. Am J Public 
Health, 2018. 108(4): p. 500-502.
10 Bot, A.G., et al., Opioid use after fracture surgery 
correlates with pain intensity and satisfaction with 
pain relief.	

, 2014. 472(8): p. 
2542-9.
11 Christensen, K.P., et al., The Effects of Anesthetic 
Technique on Postoperative Opioid Consumption in 
Ankle Fracture Surgery. Clin J Pain, 2016. 32(10): 
p. 870-4.
12 Finger, A., et al., Association Between Opioid Intake 
and Disability After Surgical Management of Ankle 
Fractures. J Am Acad Orthop Surg, 2017. 25(7): p. 
519-526.
13 Helmerhorst, G.T.T., et al., Pain Relief After Operative 
Treatment of an Extremity Fracture: A Noninferiority 
Randomized Controlled Trial. J Bone Joint Surg Am, 
2017. 99(22): p. 1908-1915.
14 McDonald, E., et al., Effect of Postoperative 
Ketorolac Administration on Bone Healing in 
Ankle Fracture Surgery. Foot Ankle Int, 2018: p. 
1071100718782489.
15 Syed, U.A.M., et al., Neer Award 2018: the effect 
of preoperative education on opioid consumption in 
patients undergoing arthroscopic rotator cuff repair: 
a prospective, randomized clinical trial. J Shoulder 
Elbow Surg, 2018. 27(6): p. 962-967.
CD24 Expression in Follicular Lymphoma: An Alternative B-Cell Marker in Therapy Selected,  
Recurrent Lymphoma
Katrina Lancaster-Shorts1, Samuel Pirruccello1
1University of Nebraska Medical Center, Department of Pathology and Microbiology
Mentor: Samuel Pirruccello
Program: Pathology and Microbiology
Type: Original Research
Background: The rapidly expanding use 
of antigen targeted therapies, such as anti-
CD19, anti-CD20 and anti-CD22, in B-cell 
malignancies will require the application of 
additional B-cell-associated antigens in the 








surface density changes during normal 
maturation. In contrast to the loss of CD24 
expression in normal follicles, we observed 
that follicle center derived lymphomas retain 
CD24 expression. Our aim was to determine 
the percentage of follicle center lymphomas 
with aberrant CD24 expression.
Methods: We reviewed 334 patients with a 
diagnosis of follicular lymphoma (FL; 228), 
large cell lymphoma of follicular origin 

















tissue diagnosis of FL or diffuse large B-cell 
lymphoma (DLBCL) were excluded leaving 
113 patients with FL, 38 patients with CD10-
positive DLBCL and 12 patients with mixed 
FL/DLBCL. We analyzed the percentage of 
patients with CD24 positive lymphomas in 
each of the three diagnostic categories.
Results: We found that CD24 expression 
was retained in 89% of FLs (101/113), 63% 
(24/38) of DLBCLs and 42% (5/12) of mixed 
FL/DLBCL. Five cases of CD20 negative FL 
were CD24 positive.
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Background: Diffuse large B-cell lymphoma 
(DLBCL) is divided into cell-of-origin (COO) 
groups: germinal center B-cell (GCB), non-
















algorithms, such as the Hans and Choi, were 























Methods: We studied 70 cases of 
DLBCL analyzed with the Lymph2Cx. 
Immunohistochemistry was performed on 
FFPE tissue sections using antibodies for 
CD10, BCL6, MUM1, GCET1 and FOXP1. 
Our aim was to determine the concordance 
